LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Search

Globus Medical Inc (Class A)

Abrir

SetorSaúde

90.62 0.03

Visão Geral

Variação de preço das ações

24h

Atual

Mín

90.36

Máximo

91.41

Indicadores-chave

By Trading Economics

Rendimento

-84M

119M

Vendas

24M

769M

P/E

Médio do Setor

28.508

110.024

EPS

1.18

Margem de lucro

15.469

Funcionários

5,300

EBITDA

22M

215M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+17.56% upside

Dividendos

By Dow Jones

Próximos Ganhos

24 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

3.6B

12B

Abertura anterior

90.59

Fecho anterior

90.62

Sentimento de Notícias

By Acuity

78%

22%

324 / 351 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Globus Medical Inc (Class A) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de fev. de 2026, 23:55 UTC

Conversa de Mercado

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

22 de fev. de 2026, 23:53 UTC

Conversa de Mercado

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

22 de fev. de 2026, 23:53 UTC

Conversa de Mercado

Key China Rates Likely to Be Held Steady for Now -- Market Talk

22 de fev. de 2026, 23:51 UTC

Conversa de Mercado

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

22 de fev. de 2026, 23:35 UTC

Conversa de Mercado

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

22 de fev. de 2026, 23:21 UTC

Ganhos

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

22 de fev. de 2026, 23:20 UTC

Ganhos

Nickel Industries 2025 Operating Profit US$126.4 Million

22 de fev. de 2026, 23:19 UTC

Ganhos

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

22 de fev. de 2026, 23:19 UTC

Ganhos

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

22 de fev. de 2026, 23:18 UTC

Ganhos

Nickel Industries Won't Pay a Final Dividend

22 de fev. de 2026, 23:16 UTC

Ganhos

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

22 de fev. de 2026, 21:35 UTC

Ganhos

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

22 de fev. de 2026, 21:34 UTC

Ganhos

Ampol Says F&I Australia, International Have Begun 2026 Strongly

22 de fev. de 2026, 21:34 UTC

Ganhos

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

22 de fev. de 2026, 21:33 UTC

Ganhos

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

22 de fev. de 2026, 21:33 UTC

Ganhos

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

22 de fev. de 2026, 21:28 UTC

Ganhos

Ampol Final Dividend A$0.60/Share

22 de fev. de 2026, 21:28 UTC

Ganhos

Ampol FY Revenue A$31.37 Billion, Down 10%

22 de fev. de 2026, 21:28 UTC

Ganhos

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

22 de fev. de 2026, 21:28 UTC

Ganhos

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

21 de fev. de 2026, 14:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21 de fev. de 2026, 05:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

20 de fev. de 2026, 23:12 UTC

Aquisições, Fusões, Aquisições de Empresas

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20 de fev. de 2026, 22:12 UTC

Ganhos

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

20 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

20 de fev. de 2026, 21:23 UTC

Ganhos

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20 de fev. de 2026, 21:20 UTC

Conversa de Mercado

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20 de fev. de 2026, 21:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20 de fev. de 2026, 20:38 UTC

Conversa de Mercado

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Comparação entre Pares

Variação de preço

Globus Medical Inc (Class A) Previsão

Preço-alvo

By TipRanks

17.56% parte superior

Previsão para 12 meses

Média 106.5 USD  17.56%

Máximo 118 USD

Mínimo 87 USD

Com base em 14 analistas de Wall Street que oferecem metas de preço de 12 meses para Globus Medical Inc (Class A) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

14 ratings

11

Comprar

3

Manter

0

Vender

Pontuação Técnica

By Trading Central

72.18 / 73.07Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

324 / 351 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat